Correlation Between Algernon Pharmaceuticals and PsyBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Algernon Pharmaceuticals and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algernon Pharmaceuticals and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Algernon Pharmaceuticals and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on Algernon Pharmaceuticals and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algernon Pharmaceuticals with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algernon Pharmaceuticals and PsyBio Therapeutics.
Diversification Opportunities for Algernon Pharmaceuticals and PsyBio Therapeutics
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Algernon and PsyBio is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Algernon Pharmaceuticals and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and Algernon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algernon Pharmaceuticals are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of Algernon Pharmaceuticals i.e., Algernon Pharmaceuticals and PsyBio Therapeutics go up and down completely randomly.
Pair Corralation between Algernon Pharmaceuticals and PsyBio Therapeutics
Assuming the 90 days horizon Algernon Pharmaceuticals is expected to generate 47.12 times less return on investment than PsyBio Therapeutics. But when comparing it to its historical volatility, Algernon Pharmaceuticals is 5.1 times less risky than PsyBio Therapeutics. It trades about 0.01 of its potential returns per unit of risk. PsyBio Therapeutics Corp is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 3.74 in PsyBio Therapeutics Corp on September 3, 2024 and sell it today you would lose (3.73) from holding PsyBio Therapeutics Corp or give up 99.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Algernon Pharmaceuticals vs. PsyBio Therapeutics Corp
Performance |
| Timeline |
| Algernon Pharmaceuticals |
| PsyBio Therapeutics Corp |
Algernon Pharmaceuticals and PsyBio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Algernon Pharmaceuticals and PsyBio Therapeutics
The main advantage of trading using opposite Algernon Pharmaceuticals and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algernon Pharmaceuticals position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.| Algernon Pharmaceuticals vs. Cellectis SA | Algernon Pharmaceuticals vs. Biotron Limited | Algernon Pharmaceuticals vs. Resverlogix Corp | Algernon Pharmaceuticals vs. Covalon Technologies |
| PsyBio Therapeutics vs. Health Sciences Gr | PsyBio Therapeutics vs. Vg Life Sciences | PsyBio Therapeutics vs. MedMira | PsyBio Therapeutics vs. Oxford Cannabinoid Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |